Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
COMPASS Pathways plc

COMPASS Pathways plc (CMPS) Stock Overview

Explore COMPASS Pathways plc’s financial performance, market position, analyst ratings, and future outlook.

CMPS●NASDAQ
HealthcareMedical - Care Facilities
$10.90
$0.05(0.46%)
U.S. Market opens in 10h 14m

COMPASS Pathways plc (CMPS)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio-5.17
EPS (TTM)$-2.05
ROE-1.51%
Fundamental Analysis

AI Price Forecasts

1 Month$12.62
3 Months$15.45
1 Year Target$11.05

CMPS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of COMPASS Pathways plc (NASDAQ: CMPS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, COMPASS Pathways plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CMPS on the NASDAQ shows an RSI of 36.34, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.05 for the NASDAQ listing.

Key metrics behind COMPASS Pathways plc's NASDAQ-traded stock include a P/E ratio of -5.17 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CMPS on the NASDAQ.

Price Performance (NASDAQ: CMPS)

1-Day Change
0.46%
5-Day Change
-7.78%
1-Month Change
-27.67%
3-Month Change
30.07%
6-Month Change
60.53%
Year-to-Date (YTD) Change
57.97%
1-Year Change
154.08%
3-Year Change
16.95%
5-Year Change
-69.66%
All-Time (Max) Change
-62.41%

Contact Information

https://compasspathways.com
44 64 6905 3974
33 Broadwick Street, London, CH, W1F 0DQ

Company Facts

1,560 Employees
IPO DateSep 18, 2020
CountryGB
Actively Trading

Frequently Asked Questions